Study on the Location of Private Clinics Based on K-Means Clustering Method and an Integrated Evaluation Model

by Xiaojia Wang, Changyan Shao, Sheng Xu, Shanshan Zhang, Weiqun Xu, Yuxiang Guan
Published 2020-01-01

Long non-coding RNA FOXD3 antisense RNA 1 augments anti-estrogen resistance in breast cancer cells through the microRNA-363/ trefoil factor 1/ phosphatidylinositol 3-kinase/protein...

by Lili Ren, Huanhuan Zhou, Lei Lei, Yongjun Zhang, Hu Cai, Xiaojia Wang
Published 2021-01-01

Sequential Prediction of Glycosylated Hemoglobin Based on Long Short-Term Memory with Self-Attention Mechanism

by Xiaojia Wang, Wenqing Gong, Keyu Zhu, Lushi Yao, Shanshan Zhang, Weiqun Xu, Yuxiang Guan
Published 2020-09-01

An integrated model to evaluate the impact of social support on improving self-management of type 2 diabetes mellitus

by Xiaojia Wang, Linglan He, Keyu Zhu, Shanshan Zhang, Ling Xin, Weiqun Xu, Yuxiang Guan
Published 2019-10-01

A Modified Theoretical Model to Accurately Account for Interfacial Roughness in Predicting the Interfacial Thermal Conductance

by Yingying Zhang, Yingying Zhang, Dengke Ma, Dengke Ma, Yi Zang, Yi Zang, Xiaojia Wang, Nuo Yang, Nuo Yang
Published 2018-06-01

Non-Invasive Biomarkers for Early Detection of Breast Cancer

by Jiawei Li, Xin Guan, Zhimin Fan, Lai-Ming Ching, Yan Li, Xiaojia Wang, Wen-Ming Cao, Dong-Xu Liu
Published 2020-09-01

The CYP19 RS4646 polymorphism IS related to the prognosis of stage I-II and operable stage III breast cancer.

by Xiying Shao, Yong Guo, Xiaohong Xu, Yabing Zheng, Jiwen Wang, Zhanhong Chen, Jian Huang, Ping Huang, Jufen Cai, Xiaojia Wang
Published 2015-01-01

The Role of Adjuvant Chemotherapy in Metaplastic Breast Carcinoma: A Competing Risk Analysis of the SEER Database

by Tian Lan, Tian Lan, Yunyan Lu, Ruzhen Zheng, Xiying Shao, Hua Luo, Junling He, Huifen Yang, Haibin Xu, Xiaojia Wang, Zujian Hu
Published 2021-04-01

Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling

by Zhanhong Chen, Tian Sun, Ziyan Yang, Yabing Zheng, Ruoying Yu, Xue Wu, Junrong Yan, Yang W Shao, Xiying Shao, Wenming Cao, Xiaojia Wang
Published 2020-02-01

EGFR tyrosine kinase inhibitors activate autophagy as a cytoprotective response in human lung cancer cells.

by Weidong Han, Hongming Pan, Yan Chen, Jie Sun, Yanshan Wang, Jing Li, Weiting Ge, Lifeng Feng, Xiaoying Lin, Xiaojia Wang, Xian Wang, Hongchuan Jin
Published 2011-01-01

The RNA helicase DDX5 promotes viral infection via regulating N6-methyladenosine levels on the DHX58 and NFκB transcripts to dampen antiviral innate immunity.

by Jian Xu, Yunhong Cai, ZhenBang Ma, Bo Jiang, Wenxiao Liu, Jing Cheng, Nannan Guo, Zishu Wang, Joshua E Sealy, Cuiping Song, Xiaojia Wang, Yongqing Li
Published 2021-04-01

Everolimus‐containing therapy vs conventional therapy in the treatment of refractory breast cancer patients with PI3K/AKT/mTOR mutations: A retrospective study

by Zhanhong Chen, Yabing Zheng, Wenming Cao, Yuzi Zhang, Zhengyi Zhao, Guoqiang Wang, Jing Zhao, Shangli Cai, Xiying Shao, Jian Huang, Weiwu Ye, Yuan Huang, Wei Li, Xiang Huang, Hao Wu, Xiaojia Wang, Yongmei Yin
Published 2019-09-01

Efficacy and safety of everolimus in combination with trastuzumab and paclitaxel in Asian patients with HER2+ advanced breast cancer in BOLERO-1

by Masakazu Toi, Zhimin Shao, Sara Hurvitz, Ling-Ming Tseng, Qingyuan Zhang, Kunwei Shen, Donggeng Liu, Jifeng Feng, Binghe Xu, Xiaojia Wang, Keun Seok Lee, Ting Ying Ng, Antonia Ridolfi, Florence Noel-baron, Francois Ringeisen, Zefei Jiang
Published 2017-04-01

Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer: A Nation-Wide Multicenter Epidemiological Study in China

by Yun Wu, Yiqun Han, Pei Yu, Quchang Ouyang, Min Yan, Xiaojia Wang, Xichun Hu, Zefei Jiang, Tao Huang, Zhongsheng Tong, Shusen Wang, Yongmei Yin, Hui Li, Runxiang Yang, Huawei Yang, Yuee Teng, Tao Sun, Li Cai, Hongyuan Li, Xi Chen, Jianjun He, Xinlan Liu, Shune Yang, Youlin Qiao, Jinhu Fan, Jiayu Wang, Binghe Xu
Published 2021-02-01

Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020

by Jianbin Li, Haibo Wang, Cuizhi Geng, Zhenzhen Liu, Ying Lin, Jianyun Nie, Gang Sun, Quchang Ouyang, Xiaojia Wang, Xingrui Li, Yinhua Liu, Qianjun Chen, Peifen Fu, Feng Yao, Jishang Chen, Yiding Chen, Haidong Zhao, Yongmei Yin, Jingjie Zhang, Jiayi Chen, Xiangshun Kong, Jing Cheng, Haiqing Zhang, Shijun Peng, Geng Wang, Feng Jin, Yunjiang Liu, Gang Wu, Shengrong Sun, Zefei Jiang
Published 2020-09-01

Profile, treatment patterns, and influencing factors of anthracycline use in breast cancer patients in China: A nation‐wide multicenter study

by Fengzhu Guo, Zongbi Yi, Wenna Wang, Yiqun Han, Pei Yu, Su Zhang, Quchang Ouyang, Min Yan, Xiaojia Wang, Xichun Hu, Zefei Jiang, Tao Huang, Zhongsheng Tong, Shusen Wang, Yongmei Yin, Hui Li, Runxiang Yang, Huawei Yang, Yuee Teng, Tao Sun, Li Cai, Hongyuan Li, Xi Chen, Jianjun He, Xinlan Liu, Shune Yang, Jinhu Fan, Youlin Qiao, Jiayu Wang, Binghe Xu
Published 2021-10-01